We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Recommends More Hydrocodone Combo Restrictions
FDA Panel Recommends More Hydrocodone Combo Restrictions
February 1, 2013
An FDA advisory panel voted 19–10 to recommend up-scheduling hydrocodone combination products to schedule II controlled substances on Jan. 25, a move that would bring tighter restrictions on the opioid painkillers.